1 A Multi-center Prospective Study for Implementation of an MRI-Only Prostate Treatment Planning Workflow.

2 Development and validation of an LC-MS/MS method for the simultaneous determination of bisphenol A and its chlorinated derivatives in adipose tissue.

3 Machine learning applications in prostate cancer magnetic resonance imaging.

4 Impact of DPP4 Inhibitors in Survival of Patients With Prostate, Pancreas, and Breast Cancer.

5 management of prostate abscess in the absence of guidelines

6 clinical significance of the resistive index of prostatic blood flow according to prostate size in benign prostatic hyperplasia

7 typical and unusual cases of female genital tuberculosis

8 adding gentamicin to fluoroquinolone-based antimicrobial prophylaxis reduces transrectal ultrasound-guided prostate biopsy-related infection rate

9 vascularized tunica vaginalis interposition flap for the treatment of recto-urethral fistulas

10 phase two steroid metabolism and its roles in breast and prostate cancer patients

11 effects of l-glutamine oral supplementation on prostate of irradiated rats

12 emphysematous prostatitis caused by klebsiella pneumoniae

13 testosterone replacement therapy: long-term safety and efficacy

14 clinical and pathological characteristics of hard nodules resistant to morcellation during holmium laser enucleation of the prostate

15 metastatic oral and maxillofacial tumors in a tertiary referral hospital: retrospective analysis of eight cases and review of the literature

16 difference between actual vs. pathology prostate weight in turp and radical robotic-assisted prostatectomy specimen

17 disseminated tuberculosis with prostatic abscesses in an immunocompromised patient—a case report and review of literature

18 the emergence of extracellular vesicles in urology: fertility, cancer, biomarkers and targeted pharmacotherapy

19 correlation between tumor extent in radical prostatectomies and preoperative psa, histological grade, surgical margins, and extraprostatic extension: application of a new practical method for tumor extent evaluation

20 transurethral resection of prostate: a comparison of standard monopolar versus bipolar saline resection

21 vascular endothelial growth factor (vegf) and prostate pathology

22 prediction of complications due to intratissue radiotherapy in multimodality treatment for prostate cancer

23 the frequency of latent prostate carcinoma in autopsies of over 50 years old males, the iranian experience

24 benign prostatic hyperplasia and new treatment options – a critical appraisal of the urolift system

25 second to fourth digit ratio: its relationship with core cancer volume and gleason score in prostate biopsy

26 the relationship between prostate cancer and apoptosis

27 clinical-pharmacological value of treatment efficiency of bhp-patients by antithrombotic therapy

28 [Urinary tract hemangiopericytoma treated with radical surgery and neoadjuvant chemotherapy. Report of two cases.].

29 [Clinical Retrospective Analysis of Chronic Myeloid Leukemia in Myeloid Blast Crisis].

30 Gender inequality in genitourinary malignancies clinical trials leadership.

31 Visualization and Cytotoxicity of Fluorescence-Labeled Dimeric Magnetite-Gold Nanoparticles Conjugated with Prostate-Specific Membrane Antigen in Mouse Macrophages.

32 Dihydrotestosterone Increases Cytotoxic Activity of Macrophages on Prostate Cancer Cells via TRAIL

33 Use of vitamin K antagonists and risk of prostate cancer: Meta–analysis and nationwide case–control study

34 Risk factors for infectious complications following transrectal ultrasound-guided prostate biopsy

35 Strategies for prevention of ultrasound guided prostate biopsy infections [Erratum]

36 Strategies for prevention of ultrasound-guided prostate biopsy infections

37 Risk factors for infectious complications following transrectal ultrasound-guided prostate biopsy

38 Stauffer’s Syndrome in Patient with Metastatic Prostate Cancer

39 Strategies for prevention of ultrasound guided prostate biopsy infections [Erratum]

40 Development of resveratrol-conjugated gold nanoparticles: interrelationship of increased resveratrol corona on anti-tumor efficacy against breast, pancreatic and prostate cancers.

41 Evaluating the Impact of Post-Treatment Self-Management Guidelines for Prostate Cancer Survivors.

42 Correction: Prostate cancer in world trade center responders demonstrates evidence of an inflammatory cascade (Molecular Cancer Research (2019) 17 (1605–1612) DOI: 10.1158/1541-7786.MCR-19-0115.Epub)

43 A Qualitative Study to Determine Barriers for Prostate Cancer Screening in Rural African-American Men.

44 "Real-world" evaluation of F-Choline PET/CT practices in prostate cancer patients and impact on changes in therapeutic strategy.

45 Metagenomic analysis reveals a rich bacterial content in high-risk prostate tumors from African men.

46 Prediction of significant prostate cancer in biopsy-naïve men: Validation of a novel risk model combining MRI and clinical parameters and comparison to an ERSPC risk calculator and PI-RADS.

47 Effects of poloxamer-based thermo-sensitive sol-gel on urethral stricture after transurethral resections of the prostate for benign prostatic hyperplasia: A multicenter, single blinded, randomized controlled trial.

48 Erratum: Computer simulations suggest that prostate enlargement due to benign prostatic hyperplasia mechanically impedes prostate cancer growth (Proceedings of the National Academy of Sciences of the United States of America (2019) 116 (1152–1161) DOI: 10.1073/pnas.1815735116)

49 Comparison of multivariate adaptive regression splines and logistic regression in detecting SNP-SNP interactions and their application in prostate cancer.

50 The role of salvage brachytherapy for local relapse after external beam radiotherapy for prostate cancer.

51 A History of Past Prostate Cancer Still Carries Risk After Total Knee Arthroplasty.

52 Prostate cancer cutaneous metastasis. Brief review of the urologic literature and Spanish authors (1983-2019)

53 Normal 3T MR Anatomy of the Prostate Gland and Surrounding Structures.

54 Persistent Homology for the Quantitative Evaluation of Architectural Features in Prostate Cancer Histology

55 Melatonin and Docosahexaenoic Acid Decrease Proliferation of PNT1A Prostate Benign Cells via Modulation of Mitochondrial Bioenergetics and ROS Production

56 Development and validation of an animal model of prostate inflammation-induced chronic pelvic pain: evaluating from inflammation of the prostate to pain behavioral modifications.

57 The association of intraprostatic calcifications and dosimetry parameters with biochemical control after permanent prostate implant.

58 Ouabain induces apoptotic cell death in human prostate DU 145 cancer cells through DNA damage and TRAIL pathways.

59 Regular vs. selective use of closed suction drains following robot-assisted radical prostatectomy: results from a regional quality improvement collaborative.

60 Competing Endogenous RNA and Coexpression Network Analysis for Identification of Potential Biomarkers and Therapeutics in association with Metastasis Risk and Progression of Prostate Cancer.

61 Are superior cervical sympathetic ganglia avid on whole body 68Ga-PSMA-11 PET/magnetic resonance?: a comprehensive morphologic and molecular assessment in patients with prostate cancer.

62 Challenges and Prospects of Chimeric Antigen Receptor T-cell Therapy for Metastatic Prostate Cancer.

63 Self-assembled albumin nanoparticles for combination therapy in prostate cancer

64 Correction: Griffith, D.M., et al. Novel Improved Synthesis of HSP70 Inhibitor, Pifithrin-μ. In Vitro Synergy Quantification of Pifithrin-μ Combined with Pt Drugs in Prostate and Colorectal Cancer Cells. Molecules 2016, 21, 949

65 Gleason Score Correlation Between Prostate Needle Biopsy and Radical Prostatectomy Materials.

66 Assessment of the influence of transrectal and transperineal prostate biopsies on erectile function: A prospective observational single-center study.

67 Oncological and functional outcomes of a large Canadian robotic-assisted radical prostatectomy database with 10 years of surgical experience.

68 The incidence proportion of erectile dysfunction in patients treated with cryotherapy for prostate cancer: a meta-analysis

69 Effect of Vitamin D Supplementation in Prostate Cancer: A Systematic Review of Randomized Control Trials.

70 Metal- and redox homeostasis in prostate cancer with vitamin D supplementation.

71 Re: Vitamin D3 Prevents Calcium-Induced Progression of Early-Stage Prostate Tumors by Counteracting TRPC6 and Calcium Sensing Receptor Upregulation.

72 Vitamin D in prostate cancer.

73 Dose Escalation of Vitamin D Yields Similar Cryosurgical Outcome to Single Dose Exposure in a Prostate Cancer Model.

74 1,25(OH)D disrupts glucose metabolism in prostate cancer cells leading to a truncation of the TCA cycle and inhibition of TXNIP expression.

75 microRNAs and DICER1 are regulated by 1,25-dihydroxyvitamin D in prostate stroma.

76 Prostate cancer: Calcium promotes cancer; vitamin D decelerates.

77 Vitamin D3 Prevents Calcium-Induced Progression of Early-Stage Prostate Tumors by Counteracting TRPC6 and Calcium Sensing Receptor Upregulation.

78 Phase IIa, randomized placebo-controlled trial of single high dose cholecalciferol (vitamin D) and daily Genistein (G-2535) versus double placebo in men with early stage prostate cancer undergoing prostatectomy.

79 Phase 2 trial of weekly intravenous 1,25 dihydroxy cholecalciferol (calcitriol) in combination with dexamethasone for castration-resistant prostate cancer

80 Cholecalciferol (Vitamin D3) and the retinoid N-(4-hydroxyphenyl)retinamide (4-HPR) are synergistic for chemoprevention of prostate cancer

81 Cholecalciferol (vitamin D<inf>3</inf>) inhibits growth and invasion by up-regulating nuclear receptors and 25-hydroxylase (CYP27A1) in human prostate cancer cells

82 Chemoprevention of prostate cancer by cholecalciferol (vitamin D <inf>3</inf>): 25-Hydroxylase (CYP27A1) in human prostate epithelial cells

83 Designing a randomized phase I/II prostate cancer chemoprevention trial using 1α-hydroxy-24-ethyl-cholecalciferol, an analogue of vitamin D <inf>3</inf>

84 20-Cyclopropyl-cholecalciferol vitamin D<inf>3</inf>analogs: A unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines

85 Protective Innate Immune Variants in Racial/Ethnic Disparities of Breast and Prostate Cancer.

86 Management of patients with metastatic prostate cancer (mPC) in a rural part of North Norway with a scattered population: does living near the department of oncology translate into a different pattern of care and survival?

87 Automating the Capture of Structured Pathology Data for Prostate Cancer Clinical Care and Research.

88 System Integration and Preliminary Clinical Evaluation of a Robotic System for MRI-Guided Transperineal Prostate Biopsy.

89 Machine learning methods can more efficiently predict prostate cancer compared with prostate-specific antigen density and prostate-specific antigen velocity.

90 Photodynamic therapy for prostate cancer: a systematic review and meta-analysis.

91 Impact of time from diagnosis to treatment on erectile function outcomes after radical prostatectomy.

92 Irreversible Electroporation for the Ablation of Prostate Cancer.

93 Therapeutic substitutions in the midst of new technology diffusion: The case of treatment for localized prostate cancer.

94 Prostate cancer: Open vs laparoscopic vs robotic RP - The biggest study to date

95 The development and comparative effectiveness of a patient-centered prostate biopsy report: a prospective, randomized study.

96 Concordance Between Biopsy and Radical Prostatectomy Pathology in the Era of Targeted Biopsy: A Systematic Review and Meta-analysis.

97 Targeting prostate cancer cell proliferation, stemness and metastatic potential using derived phytochemicals.

98 Illness uncertainty, partner support, and quality of life: A dyadic longitudinal investigation of couples facing prostate cancer.

99 MicroRNA biogenesis, gene silencing mechanisms and role in breast, ovarian and prostate cancer.

100 Evaluation of a deep learning-based pelvic synthetic CT generation technique for MRI-based prostate proton treatment planning.

101 Statin use and longitudinal changes in prostate volume; results from the REDUCE trial.

Keyword Connections

Journals

Research Groups

Bibliographies